Skip to main content
SpringerLink
Log in

Androgen receptor pathway inhibitor-related MACE

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cardiovascular Adverse Events Associated With New-Generation Androgen Receptor Pathway Inhibitors (ARPI) for Prostate Cancer: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS) Clinical Genitourinary Cancer : 8 Jul 2023. Available from: URL: https://doi.org/10.1016/j.clgc.2023.07.003

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Androgen receptor pathway inhibitor-related MACE. Reactions Weekly 1967, 5 (2023). https://doi.org/10.1007/s40278-023-43812-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-43812-9

Search

Navigation